Skip to Content

Metreleptin Pregnancy and Breastfeeding Warnings

Metreleptin is also known as: Myalept

Metreleptin Pregnancy Warnings

Use of metreleptin is not recommended unless the benefit outweighs the risk to the developing fetus. US FDA pregnancy category: C Comment: Pregnancy registry: Patients or physicians should call 1-855-6MYALEPT to enroll.

There are no adequate and well-controlled studies in pregnant women. In a pre- and postnatal development study in mice, the administration of metreleptin caused prolonged gestation and dystocia resulting in maternal death during parturition and lower survival of the fetus at the maximum recommended doses. US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Metreleptin Breastfeeding Warnings

A decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother. Excreted into human milk: Unknown Excreted into animal milk: Data not available Comments: Endogenous leptin is present in human milk. There is a potential for serious adverse reactions related to passage of anti-metreleptin antibodies in nursing infants.

See references

References for pregnancy information

  1. "Product Information. Myalept (metreleptin)." Bristol-Myers Squibb, Princeton, NJ.

References for breastfeeding information

  1. "Product Information. Myalept (metreleptin)." Bristol-Myers Squibb, Princeton, NJ.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.